Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Author Archives: admin

You are here:
  1. Home
  2. Article author admin

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminJanuary 5, 2023
ZoomDetails

2022 Annual Report

Annual ReportsBy adminDecember 30, 2022
Details

BOD Report FY2022

BOD ReportsBy adminDecember 30, 2022

Rameda acquires exclusive rights for the distribution and marketing of “Physiomer” in Egypt

Corporate NewsBy adminDecember 20, 2022

Disclosure regarding Rameda acquiring exclusive rights for the distribution and marketing of “Physiomer” in Egypt

Regulatory DisclosuresBy adminDecember 20, 2022

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminDecember 14, 2022
Details

BOD Meeting Minutes on 14 December 2022

Board and Shareholders ActionsBy adminDecember 14, 2022
Details

ESG 3Q22 Presentation

ESG PresentationsBy adminNovember 30, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 28, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminNovember 20, 2022
←1
234567
…89101112…
131415161718192021222324252627282930313233343536
37→

All Rights Reserved © 2024

Go to Top